| 摘要 |
This invention provides a pharmaceutical composition for preventing or reversing pulmonary inflammation in a mammal comprising rapamycin prepared by processes known per se and if desired a pharmaceutically acceptable carrier, diluent or exci- pient; said composition being adapted for administration orally, parenterall y, nasally, or intrabronchially. As such, rapamycin is useful in providing the symptomatic relief of diseases in which pulmonary inflammation is a component, such as, asthma, chron- ic obstructive pulmonary disease, emphysema, acute respiratory distress syndrome, bronchitis, and the like.
|
